Staff editor
Professor Jacques Ravel, from University of Maryland School of Medicine and LUCA Biologics, discusses his latest research and therapeutic innovations in the field of vaginal microbiome modulation.
Celine Druart, from the Pharmabiotic Research Institute, discusses the new European regulation concerning substances of human origin and the impact on microbiome research and therapeutic development.
Preclinical findings will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.
This pioneering three-in-one formula uniquely combines pasteurized Akkermansia muciniphila AKK PROBIO, DigeSEB® broad-spectrum digestive enzymes, and B-Complex vitamins.
Matthew Cheng, CEO of Kanvas Biosciences, introduces the company’s cutting-edge spatial biology platform, developed to provide deeper insights into host-microbiome interactions.
Treatment with the probiotic Lactobacillus murinus improved social behavior and partially restored gut and brain function.
Maitrayee Chatterjee, Ph.D., Project Manager and Senior Scientist at InnoGI Technologies, discusses their innovative and non-invasive platform to mimic both the upper and lower gastrointestinal tract, offering precise and standardized…
Industry
Sponsored by
Cerenity™ improves mobility, strength, and muscle function in older adults by modulating the gut-muscle axis.
The Human Gut Microbiome Reference Material (RM) promises to standardize and enhance research efforts in a field poised to transform healthcare.
MaaT013, a Microbiome Ecosystem Therapy™ (MET), is designed to restore the gut microbiome in pediatric patients aged 6 to 18 years with steroid-resistant aGvHD.
